For over 100 years Dutch multinational DSM has dedicated itself to advancing health, bioscience, and nutrition.
Not one to rest on tradition, in 2020 the company took a transformational approach to its Order-to-Cash (O2C) process after realizing the team spent too much time on manual interventions, and then trying to fix the issues those interventions unintentionally caused.
Using Celonis’ Execution Management System (EMS) and supported by Accenture at every step, DSM has since enhanced on-time delivery and cash flow through process optimization. It took just three months (the pilot phase) for DSM to realize value, including multi-million-dollar savings thanks to decreased O2C lead times.
“We uncovered many of the manual process steps ripe for automation early on, with working capital improvement as one of the attractive benefits,” explained Marc Daams, DSM Celonis Lead. “Before working with Celonis, we could extract data but it was hard to comprehend and the team spent hours digging into each line item to try and identify the problems.” He added: “We have significantly improved our capability to identify the best opportunities for automation to fix O2C processes and make them happen.”